Nel ASA

Phase A — Understand the business

Lens 1 · Company Overview

What it is. Nel ASA is a Norwegian hydrogen-electrolyser pure-play — it designs and manufactures the machines that split water into hydrogen and oxygen using electricity. Since the June 2024 spin-off of its hydrogen-fueling division (now the separately-listed Cavendish Hydrogen ASA, OB:CAVEN), Nel is a two-technology electrolyser company and nothing else. Founded lineage traces to Norsk Hydro's 1927 electrolyser work; the modern Nel has been a listed hydrogen pure-play since ~2014.

How it makes money. Nel sells electrolyser stacks and systems (capital equipment) to hydrogen-project developers, industrial gas companies, EPC contractors, and increasingly governments/defense. Revenue is project/order-driven, lumpy, and equipment-margin — not recurring. A customer takes a final investment decision (FID) on a green-hydrogen plant, places a purchase order, Nel manufactures and delivers over 12–30 months, and recognises revenue on delivery/milestones. There is a small aftermarket/service tail but the P&L is dominated by new-build equipment. This is the core structural problem: no FIDs → no orders → no revenue, and the whole green-hydrogen market has been in an FID depression since 2023.

Two product lines / segments:

• Alkaline (mature, lower-cost-per-kW, large-scale) — manufactured at the Herøya, Norway automated factory. The historic flagship; idled in Jan 2025 for lack of demand. Being relaunched around a new pressurized alkaline platform (below).
• PEM / proton-exchange membrane (premium, dynamic, better for variable renewables and smaller/containerized deployments) — manufactured at Wallingford, Connecticut, expanded to ~500 MW capacity in 2025. PEM is currently carrying Nel's order momentum (US industrial, utility, and US Navy orders).

Customers. Green-hydrogen developers and industrials, heavily Nordic/European plus US. Named 2025–26 buyers: Kaupanes Hydrogen / HyFuel (Norway, >USD 50m PEM, Nov 2025), Statkraft (Norway — but cancelled its 40 MW alkaline order), Mesure Process / Synqo Energies (Europe, USD 7m PEM), Douglas County PUD (Washington State, USD 7m PEM), a US steel producer (5 MW PEM), and the US Navy (PEM stacks). Historic marquee names: Nikola (fueling JV, now defunct) and Everfuel (2019 spin-off).

Suppliers/competitors. Suppliers = specialty materials (nickel electrodes for alkaline; iridium/platinum catalysts and titanium/membranes for PEM), power electronics, balance-of-plant. Competitors = Thyssenkrupp Nucera, Plug Power, ITM Power, John Cockerill, Siemens Energy, Cummins/Accelera, and — decisively — Chinese makers (LONGi, Sungrow, Peric) who undercut on price by 2–4x (Lens 3/13). Samsung E&A is simultaneously a 9.1% shareholder, an EPC channel partner, and provides a performance "wrap guarantee" on the new platform (Lens 9).

Contract structure. Firm purchase orders, milestone/delivery revenue recognition, no take-or-pay and no meaningful recurring revenue — the weakest possible revenue-quality profile for a capital-equipment maker in a demand trough.

Lens 2 · Supply Chain

Upstream inputs → Nel → end customer, named where sourced (`` throughout; the empty customers.csv/supply-chain.md stubs contribute nothing):

Upstream (into Nel):

• Alkaline — nickel-based electrodes, KOH electrolyte, steel/diaphragm materials. Nickel is the key commodity exposure; not a genuine chokepoint (deep global market).
• PEM — the real chokepoint. PEM depends on iridium and platinum catalysts (iridium is one of the scarcest platinum-group metals, ~7–8 tonnes/yr global supply, South-Africa-concentrated) and PFSA membranes (Nafion-type, effectively Chemours/Gore/AGC oligopoly). Large PEM scale-up is genuinely iridium-constrained industry-wide.
• Power electronics / rectifiers, balance-of-plant — standard industrial supply.
• Balance-of-Stack co-development with Samsung E&A — Nel is consolidating the balance-of-stack for alkaline with Samsung, i.e. partially outsourcing/co-engineering that layer.

Nel (manufacturing nodes):

• Herøya, Norway — automated alkaline stack factory, nameplate ~1 GW (was 500 MW, second line added), idled Jan 2025, being re-tooled for the pressurized alkaline platform (Dec 2025 FID, scaling to 1 GW then a 4 GW medium-term target).
• Wallingford, Connecticut — PEM cell/stack factory, ~500 MW capacity.
• Plymouth Township, Michigan — the $400m 4 GW gigafactory that was announced (Sept 2023) and then abandoned/frozen — never broke ground, no property option as of Mar 2025 (Lens 5/9).

Downstream (out of Nel):

• EPC / integrators — Samsung E&A packages Nel electrolysers into "complete hydrogen plants" (CompassH2-A+, 100 MW).
• Project developers / offtakers — Kaupanes/HyFuel, Statkraft, utilities (Douglas County PUD), industrials (steel), and defense (US Navy).

Chokepoints & single-source risks: (1) iridium/PFSA for PEM — an industry-wide ceiling on PEM scale, not Nel-specific; (2) demand-side chokepoint — the binding constraint is not any input but the absence of FIDs/offtake downstream; (3) Samsung dependency — Nel is increasingly leaning on one strategic partner for channel, balance-of-stack, and the credibility wrap on its flagship product. That is concentration risk dressed as a moat.

Lens 3 · Competitive Advantages (moats)

The honest verdict: the moat is thin and getting thinner. Nel has genuine assets but no durable pricing power.

• What Nel has: ~100 years of cumulative electrolyser know-how; a both-technologies portfolio (alkaline + PEM) most Western rivals lack; the world's first fully-automated alkaline stack factory; an installed base and brand recognition in Europe; a debt-free balance sheet with ~NOK 1.4bn cash that lets it survive the winter that is killing smaller peers; and now a Samsung E&A alliance (capital, EPC reach, performance guarantee).
• Where the moat fails — price. Auction data and the IEA (Global Hydrogen Review 2026) show Chinese alkaline stacks at roughly one-quarter the price of Western equivalents, and Chinese systems 2–5x cheaper overall (~$114–142/kW at the stack level). Nel's new platform targets turnkey <$1,450/kW for a 25 MW system vs the $3,000+ many Western projects face — a real ~50% cost-down, but still a system number well above bare-Chinese-stack economics. In a commoditising capital good, being the premium Western vendor is not a moat unless the buyer is paying for something else.
• The only defensible moat is non-price: "trusted / non-Chinese supply," Western/EU local-content and security-of-supply preferences, IP on the pressurized-alkaline design, and the Samsung wrap guarantee (a bankability tool that de-risks the new, unproven platform for lenders). This is a policy-and-trust moat, not a technology-or-cost moat — which is exactly why management has pivoted the pitch from "climate" to "energy security/defense" (Lens 12).
• Bargaining power: weak on both sides right now. Against customers — in a buyer's market with Chinese alternatives, Nel is a price-taker (Statkraft simply cancelled). Against suppliers — fine on commodities, but increasingly dependent on Samsung.

Switching costs, network effects, and scale advantages are all modest. The bear framing (Lens 13) is that Nel's real moat is its cash pile and its listing, not its product.

Lens 4 · Segments

segments.csv is an empty stub — all figures ``. Post-Cavendish, Nel reports two segments: Alkaline and PEM.

Geography: predominantly Europe/Nordics (alkaline projects, EU Innovation Fund support) plus a growing US PEM footprint (Wallingford-made, deployed domestically — including defense). No China exposure on the sell side (and China is the competitor, not the customer).

The tell: In Q4 2025 Nel impaired both segments simultaneously — NOK 439m of PEM goodwill/intangibles and NOK 361m of Herøya alkaline production facilities. Writing down the very assets built during the 2021–22 boom is management conceding that peak-cycle capacity was over-built for the demand that actually arrived. Backlog is now split ~24% alkaline / ~76% PEM — the opposite of the company's historic alkaline-led identity.

---

Phase B — Measure performance

Lens 5 · Earnings Result (latest print — Q1 2026, reported May 2026)

financials.csv/guidance.csv are empty stubs; all ``.

• Revenue: NOK 148m from contracts with customers, −5% YoY; total revenue & income NOK 152m (Q1'25: 175).
• EBITDA: −NOK 100m, a NOK 15m YoY improvement (cost cuts flowing through).
• Order intake: NOK 85m, −73% YoY — the headline shock. Backlog NOK 1,113m, −24% YoY.
• Segment colour: Alkaline revenue +6% YoY; PEM signed a USD 7m PO after quarter-end.
• Balance sheet: cash ~NOK 1.4bn, debt-free; a EUR 11m EU grant expected in Q2 2026.
• Market reaction: shares "turned positive" / rose intraday on the print despite weak orders — the market rewarded the cost discipline, cash cushion, and platform narrative over the collapsing order line.

Prior-period context (FY2025, reported Feb 2026):

• Revenue NOK 963m, −31% YoY (FY2024 NOK 1,390m).
• FY net loss NOK 1,265m (vs NOK 258m in 2024) — driven by Q4'25's NOK 870m loss, of which NOK 799m was non-cash impairment (NOK 439m PEM + NOK 361m alkaline). (Provenance conflict resolved: an early web summary reported a FY loss of "−121m"; the dedicated Q4 report source confirms −1,265m. The −121m figure is discarded as a mis-scrape.)
• Cash NOK 1.6bn end-2025 (down from NOK 1.9bn end-2024) — ~NOK 0.3bn annual cash burn.
• Paradox of the year: Q4'25 order intake +364% to NOK 686m (2nd-best quarter ever, PEM 93%) landing in the same quarter as a record loss.

Unusual vs its own history: the impairment is the standout — Nel spent the boom building automated capacity and is now writing it down as the market failed to show. Revenue peaked ~2024 and is falling; the Q2'25 print was −48% YoY (the trough).

Lens 6 · Earnings Calls (sentiment trend)

transcripts/ is empty; call colour is `` from summaries. Tracking the arc across 2025 → Q1 2026:

• 2025 (H1): demand shock, FIDs "pushed to coming quarters," orders "delayed, cancelled, or at risk"; management pivots to cost-out — ~25% workforce cut, 21% lower personnel cost, Herøya idled.
• Q4 2025 call (Feb 2026): tone splits — celebrating the +364% order surge and the Dec-2025 FID on the new platform while absorbing an NOK 799m impairment. "Strain and promise".
• Q1 2026 call (May 2026): "cost cuts, tech bets, thin orders." Management: higher volumes/revenues are needed before break-even; expects more FIDs in 2026 than 2025; believes momentum builds into 2027–28; leans on the NOK 1.4bn cash pile and the platform roadmap for "guarded optimism".

Shift over time: the narrative has migrated climate → cost → security. Recurring new phrases: "pressurized alkaline," "cost breakthrough," "energy independence/security," "Samsung." Phrases quietly dropped: the 2021-era "10 GW capacity by 2025" ambition, the Michigan gigafactory, and hard near-term revenue/break-even guidance. Management has stopped forecasting the top line and started forecasting FIDs — an admission that visibility is externally, not internally, controlled.

Lens 7 · Comps

Peer set = Western/listed electrolyser & fuel-cell names (the index has no populated energy peers).

Read: On EV/Sales ~3x on falling FY25 revenue (~5x on Q1'26-annualised), Nel is not cheap for a shrinking, deeply-lossmaking equipment maker — and more expensive than Nucera (~1x, bigger, near-break-even). The only genuinely cheap thing about Nel is the cash-to-market-cap ratio (~1/3), which is why it screens as a "cash-backed option" rather than a value stock. Bloom's ~$72bn cap is a reminder that the market is paying up lavishly for the fuel-cell/AI-power story while pricing electrolyser pure-plays for survival, not growth — the "hydrogen" bucket has bifurcated violently.

Lens 8 · Stock-Price Catalysts (moves >5%, ~5-year lookback)

All ``. Pattern-hunting across the arc:

• Jan 8, 2021 — all-time high NOK 35.15: peak hydrogen mania (Biden election, Nikola JV, ESG inflows).
• 2020–22 — the long crash: Hindenburg's Nikola fraud report (Sept 2020) + rising rates + hype deflation. Nel eventually sold all ~1.1m Nikola shares for ~USD 7.5m.
• Mar 2022 — NOK 1,500m raise at NOK 15.3/share, 4.5x oversubscribed (largest in Nel history) — a dilution milestone.
• Sept 2023 — Michigan gigafactory announced ($400m, 517 jobs, IRA optimism) — later abandoned.
• Jun 2024 — Cavendish spin-off completed (1 CAVEN per 50 NEL).
• Jan 2025 — Herøya idled + ~25% layoffs: the demand-shock capitulation.
• Mar 11, 2025 — Samsung E&A private placement (9.1%, NOK 353m): a rare positive catalyst.
• Nov 2025 — Kaupanes/HyFuel >USD 50m PEM order → Q4 order intake +364%.
• Dec 2025 — FID on new alkaline platform + EU Innovation Fund (up to €135m).
• Feb 2026 — Q4'25 NOK 799m impairment / NOK 1,265m FY loss.
• May 6, 2026 — pressurized alkaline platform launch ("60% cost cut").
• Jun 15, 2026 — CEO Volldal resigns (to Elopak) → stock drop.
• 2026 YTD — +57% despite orders −73%: the decoupling.

What the pattern reveals: Nel's stock is a policy-, partnership-, and narrative-beta instrument, not an earnings compounder. It moves on capital raises, spins, government/EU money, marquee partners (Samsung), and macro hydrogen sentiment — and is remarkably insensitive to its own (uniformly bad) earnings. The 59% retail ownership amplifies momentum both ways. The 2026 rally on a −73% order quarter is the purest example: this is a story stock trading on option value, and the story currently outruns the fundamentals.

---

Phase C — Judge people & books

Lens 9 · Management

• CEO — Håkon Volldal (departing). Joined July 2022 from Q-Free/Tomra; resigned June 15, 2026 to become CEO of packaging firm Elopak, effective early 2027 (6-month notice, stays ~to Dec 2026). On his watch: renewed the product portfolio (culminating in the pressurized-alkaline platform), landed the Samsung alliance, executed the Cavendish spin — but presided over the revenue collapse, the Herøya idling, the ~25% headcount cut, the Michigan reversal, and a NOK 799m impairment. He leaves for a completely different industry at the exact moment the company's make-or-break platform ramp begins — read that how you will. No successor named; an "empty captain's chair" during the ramp.
• Chairman — Arvid Moss. Ex-Norsk Hydro executive VP, ex-NHO (Confederation of Norwegian Enterprise) president; MSc NHH. Establishment Norwegian-industry figure. Holds ~100,000 shares.
• Skin in the game — weak. Insiders own <1% in their own names; total board holdings ~NOK 706k — trivial against a NOK 4.29bn cap. This is a professional-manager company, not a founder-owner one — no large aligned insider betting personal wealth on the outcome.
• Ownership structure — retail-dominated: ~59% individuals, ~29% institutions; largest holder Samsung E&A at 9.1% (2-year lockup, board seat), #2/#3 ~3.4% each. Samsung is now the de facto anchor — a strategic, not purely financial, holder.
• Capital-allocation history — value-destructive to date. Serial equity issuance funded capacity built ahead of demand that didn't arrive; that capacity was then idled and impaired; the flagship US gigafactory was announced with fanfare, took ~$200m of promised subsidy, and was abandoned before breaking ground. ROE/ROIC have been persistently and deeply negative. The one genuinely shrewd move is defensive: keeping the balance sheet debt-free with ~NOK 1.4bn cash, which buys years of runway while weaker peers fail — plus using partner and government money (Samsung placement, EU Innovation Fund) rather than pure dilution for the new platform.
• Archetype & implication: professional stewards managing a survival-and-optionality phase, not empire-builders. For a pre-profit company that needs a founder's conviction through a multi-year winter, thin insider ownership + a departing CEO + no successor is a governance weak point, partly offset by Samsung's strategic presence on the register and board.

Lens 10 · Forensic Red Flags

financials.csv empty; figures ``. Acting as forensic analyst on a company with no SEC filings (no 10-K Item 3, no AAER surface — see below):

• Impairments are the headline flag — but they read as clean-up, not fraud. The NOK 799m Q4'25 write-down of Herøya facilities + PEM goodwill/intangibles is a cash-flow-neutral honesty event: management marking boom-era assets to depressed reality. Non-cash, disclosed, segment-attributed. More reassuring than concerning — the concern is what it says about prior capital allocation, not about accounting integrity.
• Revenue quality: milestone/delivery recognition on lumpy equipment orders is inherently susceptible to timing games; with backlog visible and shrinking, and revenue falling, there is little incentive or evidence of aggressive pull-forward. Watch percentage-of-completion treatment and any contract-asset / unbilled-receivable build as the new platform ships in H2'26–2027.
• Cash vs earnings: the divergence runs the safe way — reported losses (NOK −1,265m FY25) are far worse than cash burn (~NOK −300m), because the bulk is non-cash impairment/D&A. Cash is the number that matters here and it is being managed conservatively.
• Order-book fragility (the real red flag): backlog is a soft asset — the Statkraft 40 MW cancellation wiped NOK 120m, demonstrating that reported backlog can evaporate without penalty. Treat the NOK 1.1bn backlog as indicative, not contracted-firm.
• SBC / dilution: the multi-year pattern of equity issuance (share count now ~1.84bn) is the shareholders' true recurring cost — value has been transferred from legacy holders to fund survival. Not "aggressive accounting," but the single biggest per-share value leak.
• Going concern: not a going-concern risk near-term — ~NOK 1.4bn cash + no debt + ~NOK 0.3bn burn = multi-year runway.

Regulatory findings (required sub-section). Per regulatory/regulatory-findings.md (generated 2026-07-10): Nel ASA has no SEC CIK and is not an SEC filer, so EDGAR EFTS (Litigation Releases + AAERs) returns zero findings — no search is possible, not a clean bill. Non-SEC / web check: no material FTC/DOJ/EU enforcement, consent decree, or fraud action against Nel ASA surfaced in web search as of 2026-07-10. The historically relevant safety event — the 2019 Kjørbo (Sandvika, Norway) hydrogen refueling-station explosion — belongs to the fueling business that was spun into Cavendish Hydrogen in June 2024, and is not a liability of today's electrolyser-only Nel. As a Norwegian issuer, Nel's oversight sits with Oslo Børs / Finanstilsynet (the Norwegian FSA) under IFRS, not the SEC. Net: no material regulatory or legal findings against the electrolyser company — verified via SEC EDGAR (no CIK, inapplicable), web search, and Oslo-listing context as of 2026-07-10. Caveat: absence of an EDGAR trail means less standardized enforcement transparency than a US filer.

---

Phase D — Project & stress-test

Lens 11 · Forward Projection (FY2026E–FY2028E)

No EPS forecast is logged — this is the unattended --watchlist loop (skip forecast.ts create per SKILL), and Nel is loss-making with no credible path to positive EPS inside the 3-year window, so a point-EPS estimate would be false precision. What matters for a pre-profit equipment maker in a demand trough is revenue trajectory, cash runway, and the break-even volume gap. All off actuals; arithmetic shown.

Anchors: FY25 revenue NOK 963m; Q1'26 revenue NOK 148m (run-rate ~NOK 590–600m); backlog NOK 1,113m; cash NOK 1.4bn; burn ~NOK 300m/yr; management guides "more FIDs in 2026 than 2025," momentum into 2027–28.

• Bear (demand winter persists, China wins on price): FY26 revenue ~NOK 0.7–0.8bn (backlog burns faster than it refills; another Statkraft-type cancellation); EBITDA ~−NOK 350–400m; cash to ~NOK 1.0–1.1bn by end-27. Still solvent, but the equity is a slowly-decaying option.
• Base (slow thaw, PEM carries, platform ships): FY26 revenue ~NOK 0.9–1.1bn (roughly flat-to-up as the >USD 50m PEM order and new PEM wins deliver in H2'26–27); EBITDA ~−NOK 250–300m; FY28 revenue ~NOK 1.3–1.6bn if the pressurized-alkaline platform converts pipeline to FIDs. Break-even still not reached by FY28.
• Bull (platform + security policy re-inflects demand): the new platform's ~50% cost-down + Samsung wrap + EU/security tailwind triggers a wave of European FIDs; FY28 revenue NOK 2–3bn, approaching EBITDA break-even at the exit. Requires the green-H2 market to inflect and Nel to win share against Chinese pricing — two hard conditions.

The number that decides it isn't EPS — it's the break-even volume gap. Management concedes it needs materially higher volumes to break even. At ~NOK 0.6–1.0bn revenue the company loses money structurally; break-even likely sits somewhere north of NOK 2–3bn revenue, i.e. a 2–4x volume increase — which needs the whole sector to FID again. Runway comfortably reaches the catalysts (platform commercial traction through 2027–28) — the bet is demand, not solvency. If forced to log a Brier line in an attended run, it would be a binary: "Nel FY2027 revenue > NOK 1.5bn" — my subjective p ≈ 0.30 (base/bull blend), not an EPS threshold.

Lens 12 · Bull vs Bear

Bull case. Nel is the best-capitalised Western electrolyser survivor — debt-free, ~NOK 1.4bn cash (~1/3 of market cap, a hard floor), both alkaline and PEM, now armed with a genuinely cheaper next-gen platform (~50% turnkey cost-down) validated and de-risked by a Samsung E&A wrap guarantee, part-funded by up to €135m of EU Innovation Fund money rather than dilution. The demand cycle is at a trough that only goes one way over a decade, and the framing has shifted from optional "climate" spend to strategic energy security/sovereignty — a category governments fund through downturns. PEM order momentum (US industrial, utility, Navy) proves the commercial engine still fires. If green-hydrogen FIDs re-inflect even modestly, a NOK ~4bn company with a global brand and a cost-competitive platform has multi-bagger operating leverage. Samsung's 9.1% + board seat hints at a possible deeper combination or takeout.

Bear case (2–3 things that could permanently impair):

1. China wins the commodity war permanently. If electrolysers commoditise (they are) and Chinese stacks stay ~4x cheaper, Western pure-plays are structurally uninvestable outside protected/subsidised niches. Nel's ~50% cost-down still may not close a 4x gap — it could win the "trusted supply" niche and still be a low-margin, sub-scale business forever.
2. The demand inflection never comes at scale. Green hydrogen has been "18 months from inflection" for 5 years; ~60 projects were cancelled/postponed in 2025 and the US 45V PTC was gutted by the July-2025 "One Big Beautiful Bill". If offtake economics never close, Nel is a cash pile slowly consumed by a business that can't reach break-even volume.
3. Execution/governance air-pocket. A brand-new, unproven platform must ramp while the CEO leaves for a packaging company and no successor is named, with <1% insider ownership. Ramps go wrong; this one has no owner-operator at the wheel.

Pre-mortem (it's Jan 2028, the thesis broke — what happened?): European FIDs stayed frozen through 2026–27; the pressurized-alkaline platform shipped late and/or a lead unit underperformed, tarnishing the Samsung wrap; two more backlog cancellations hit; cash fell toward NOK 0.8bn and the market re-rated Nel from "cash-backed option" back to "melting ice cube," giving back the entire 2026 narrative rally. The new CEO cut capex and Nel quietly became a niche PEM/defense supplier — alive, but a fraction of today's valuation.

Are multiples too high? For the fundamentals, yes — EV/Sales ~3x on falling revenue with no near-term profit is a growth multiple on a shrinking business; consensus SELL with a NOK ~2.12 target below the NOK 2.34 spot says the same. The valuation is held up by cash + option value + narrative, not earnings power.

Contrarian view (what the market is refusing to see): Two-sided. The bear-consensus is refusing to see that Nel's cash floor + Samsung + EU funding + security-policy tailwind make it the last Western electrolyser standing — a genuine call option if the sector turns, and a poor short at ~1/3 cash-to-cap. The 2026-momentum bulls are refusing to see that +57% YTD on a −73% order quarter is narrative outrunning a business that just impaired its flagship and lost its CEO. Both can be true: avoid the crowd on both sides — it's neither a clean short nor a clean long here.

Lens 13 · Devil's Advocate (short-seller)

Dismantling the bull case:

• The moat is a cash pile and a listing. Strip out the ~NOK 1.4bn cash and you're paying ~NOK 2.9bn EV for a business doing ~NOK 600m run-rate revenue, falling, structurally lossmaking, in a product that China sells at a quarter the price. That is not a franchise; it's a subsidised science project with a good balance sheet.
• Revenue concentration & backlog softness. Backlog is ~76% PEM off small absolute numbers, and it is not firm — Statkraft cancelled 40 MW / NOK 120m with no consequence. A book that a single customer can delete on a whim is not the annuity bulls imply.
• Most dangerous competitor bulls underestimate: not Plug or Nucera — it's Sungrow/LONGi, vertically integrated Chinese players bundling cheap renewables and cheap electrolysers into single-vendor turnkey green-H2. Against that, Nel's "premium Western" pitch only works where buyers are legally or politically forced to avoid China. That is a shrinking, policy-dependent addressable market.
• Capital-allocation record: serial dilution to ~1.84bn shares; capacity built then idled then impaired; a US gigafactory announced, subsidised (~$200m promised), then abandoned without breaking ground. Why trust the next big capacity bet (Herøya 1→4 GW) from the same playbook?
• Governance/incentives: <1% insider ownership, a CEO exiting to packaging with no named successor mid-ramp. Nobody with real money is aligned to the outcome.
• What must hold for today's price: a green-H2 FID inflection and Nel winning share against 4x-cheaper China and a flawless first ramp of an unproven platform and a smooth CEO transition. That's a lot of ands for a stock already above its consensus target.
• Growth disappoints 20–30%: if FY26 revenue comes in ~NOK 0.7bn instead of ~NOK 1.0bn, EBITDA loss widens, cash erodes faster, and the "melting ice cube" re-rate erases the 2026 rally — plausibly back toward the NOK 1.70 Kepler target / NOK 1.00 low-end, i.e. ~30–55% downside from spot.
• Single scenario that permanently impairs: Chinese electrolysers definitively win the cost war and Western "security" preferences prove too small/slow to sustain a sub-scale Norwegian premium vendor — Nel becomes a perpetual cash-burning niche player worth little more than its (declining) cash. Plausibility: moderate-to-high — it is arguably the base rate for Western hardware vs Chinese scale.

Why not just short it? Because ~1/3 of the cap is cash, the float is 59% retail (squeeze-prone), Samsung is anchored with a board seat, and the security-policy tailwind is a real (if slow) bid. Cheap-to-borrow, but a widow-maker on narrative spikes — short interest is only ~1.1% (Citadel, Tages) for a reason.

Lens 14 · Management Questions (ordered by information value)

1. China cost gap: Your new platform targets ~$1,450/kW turnkey for 25 MW; Chinese stacks are ~$114–142/kW. In markets without local-content/security mandates, what is your realistic win-rate against Chinese turnkey bids over the next 24 months?
2. Break-even volume: At what annual revenue / GW shipped does Nel reach EBITDA break-even, and what contracted (not pipeline) backlog do you have toward it today?
3. Backlog quality: After the Statkraft cancellation, what share of the NOK 1.1bn backlog is firm with cancellation penalties vs cancellable, and what are the milestone/deposit terms?
4. CEO succession: Why does the platform ramp not require an owner-operator, and what is the timeline and profile for the new CEO — internal continuity or external turnaround?
5. Samsung: Beyond the 9.1% stake and wrap guarantee, what does the roadmap with Samsung E&A actually commit to — minimum order volumes, exclusivity, or a path to a deeper combination?
6. FID pipeline: You expect "more FIDs in 2026 than 2025." How many, at what MW, and which are Nel already down-selected on vs open tenders?
7. Herøya 1→4 GW: What demand signal justifies scaling Herøya toward 4 GW after idling it in 2025 — and what utilisation do you need to avoid another impairment?
8. Cash discipline: With ~NOK 1.4bn cash and ~NOK 0.3bn burn, what is your minimum-cash red line before you cut capex or raise, and do you rule out further equity dilution?
9. PEM iridium exposure: How is large-scale PEM constrained by iridium/PFSA supply, and what have you secured to de-risk it?
10. Michigan post-mortem: What did the abandoned gigafactory cost in capital, credibility, and subsidy clawback — and what did it change about how you commit to capacity?
11. Security pivot: Is "energy security/defense" a durable revenue category (multi-year defense/EU procurement) or a narrative bridge — quantify the security-driven order pipeline.
12. Margin path: At target platform volumes, what gross margin does the new alkaline design earn, and how does that compare to today's blended margin?
13. Consolidation: The sector faces bankruptcies/consolidation — is Nel a consolidator (using its cash) or a target, and how do you think about M&A here?
14. US policy: With 45V gutted and the construction deadline pulled to end-2027, what is your revised US (Wallingford/PEM) demand assumption?
15. Cavendish: Post-spin, are there any residual liabilities, guarantees, or shared-cost arrangements between Nel and Cavendish Hydrogen?

---